For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Biosurface Engineering Technologies, Inc.

USPTO Granted Patents = 21

EPO Patents = 2

Forward Citations = 762

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Paul O Zamora (21 out of 30 patents)

Xinhua Lin (10 out of 18 patents)

Louis A Pena (8 out of 16 patents)

4. Shigemasa Osaki (5 out of 11 patents)

5. Ray Tsang (5 out of 8 patents)

6. Kazuyuki Takahashi (4 out of 7 patents)

7. Meng Chen (3 out of 3 patents)

8. Brent Lee Atkinson (2 out of 18 patents)

9. John D Glass (2 out of 4 patents)

10. Ting-Ting Hsieh (2 out of 2 patents)

11. Sarah Campion (1 out of 1 patent)

12. Louis A Peña (1 out of 1 patent)

13. Shigemas Osaki (1 out of 1 patent)

14. Robert A Stern (1 out of 8 patents)

21 patents: Sort by Forward Citations

1. 8796212 - Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis (2014-08-05),

2. 8163717 - Dual chain synthetic heparin-binding growth factor analogs (2012-04-24),

3. 8101570 - Single branch heparin-binding growth factor analogs (2012-01-24),

4. 7981862 - Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis (2011-07-19),

5. 7820172 - Laminin-derived multi-domain peptides (2010-10-26),

6. 7700563 - Synthetic heparin-binding factor analogs (2010-04-20),

7. 7671012 - Formulations and methods for delivery of growth factor analogs (2010-03-02),

8. 7598224 - Dual chain synthetic heparin-binding growth factor analogs (2009-10-06),

9. 7528105 - Heterodimeric chain synthetic heparin-binding growth factor analogs (2009-05-05),

10. 7482427 - Positive modulator of bone morphogenic protein-2 (2009-01-27),

11. 7468210 - Cross-linked heparin coatings and methods (2008-12-23),

12. 7414028 - Growth factor analogs (2008-08-19),

13. 7297343 - Bioactive medical films (2007-11-20),

14. 7217769 - Medical device with plasma cross-linked hydrophilic coating (2007-05-15),

15. 7166574 - Synthetic heparin-binding growth factor analogs (2007-01-23),

BioSurface Engineering Technologies, Inc. is a cutting-edge biotechnology company focused on developing innovative solutions for tissue engineering and regenerative medicine. Our mission is to revolutionize the field of biomedical engineering by creating advanced biomaterials and bioactive coatings that promote tissue regeneration. With a team of leading scientists and engineers, we are committed to improving patient outcomes and transforming the way healthcare professionals address challenging medical conditions. Visit our website to learn more about our groundbreaking research and ongoing projects in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

21 Patents

#30 in Rockville, MD

#193 in Maryland

#15,143 in US

#29,011 in the World

Rockville, MD, United States of America

Biosurface Engineering Technologies, Inc.

Forward Citations = 762

14 inventors:

Paul O Zamora (21 out of 30 patents)

Xinhua Lin (10 out of 18 patents)

Louis A Pena (8 out of 16 patents)

4. Shigemasa Osaki (5 out of 11 patents)

5. Ray Tsang (5 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…